Combined with medical, overall sales grew 10% sequentially and 66% from a year ago to $168 million. The model was launched in March 2017 targeting long-term investors seeking to invest in leading cannabis stocks with low portfolio turnover and has gained 149.8% since inception compared to the 60.4% decline in the index since then. Disappointment […]
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The company has shared an objective to reach 30% share by 2024 through organic and non-organic means, which it suggests will yield $1 billion in revenue. In its Q1, overall revenue was […]
CAC’s Taunton location is also expected to receive its final adult-use license by the end of the year. The adult-use celebration will take place on Saturday, December 4, from 12 to 2pm at CAC Brockton, located at 1090 W. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis […]
Executive Chairman Jason Wild spoke with New Cannabis Ventures about the company’s footprint, the pending Gage Growth acquisition and preparing for 2022. It ultimately had to take down and reset a number of rooms. The facility is now in good shape and producing the best flower it ever has, according to Wild. The 22,000-square-foot operations […]
Upon completion of the acquisition of NuLeaf, and the previously announced Apothecarium Nevada3 acquisition, Jushi will grow its retail presence to four dispensaries in the $1.0 billion4 Nevada cannabis market, three of which are located in the bustling Las Vegas area. We are thrilled to enter into an agreement to acquire NuLeaf, a vertically integrated operator with […]
This acquisition is part of the Company’s continuing retail expansion plan in Colorado bringing the total number of dispensaries including announced acquisitions to 22. Total consideration for the acquisition will be $29 million and will be paid as 60% cash and 40% Schwazze common stock upon closing. Our team is delighted to add the Emerald […]
Against this backdrop, our strategy to partner with the thousands of diverse and talented growers in the California landscape is already showing significant benefit in lowering our costs and improving the variety of our product offering. According to Headset, the Lowell brand has regained the #1 share position in non-infused pre rolls in the market […]
The Common Shares are expected to commence trading on the Toronto Stock Exchange on a post-consolidation basis on November 18, 2021. The board of directors of Valens believes the Consolidation will result in a number of potential benefits to Valens, particularly in connection with the Company’s application for a secondary listing of the Common Shares […]
He continued, “Our New Jersey Apothecarium dispensaries will have some of the best selection and depth of product available in the state at launch. This year over year growth was driven by the acquisitions of KCR and HMS, cultivation capacity expansions in Pennsylvania, New Jersey, and California as well as an increase in the number of dispensaries from seven to thirteen. Adjusted gross margin, […]
15, 2021 , a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, is reporting its financial and operating results for the three-months and nine-months ended September 30, 2021. “When we launched our strategy at the start of the year, we envisioned that marketplace transition would take […]
, a leading and top-performing cannabis company in the United States, today announced its results for the quarter ended September 30, 2021. Q3 2021 combined results represent the simple addition of Trulieve’s reported results for the quarter ended September 30, 2021 and preliminary estimated Harvest results for the quarter ended September 30, 2021. The Company’s Form […]
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 15, 2021 / IM Cannabis Corp. Our third quarter results are indicative of the embedded growth profile of our integrated MCO model. IMC expects continued sequential revenue growth in Q4 2021 and into 2022, with recent acquisitions in Israeland Canada having been integrated, and the […]
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. One of the hardest hit parts of the market in 2021 has been the American cannabis companies, which has been evident in the performance of the AdvisorShares Pure US Cannabis ETF , […]
Approximately $250 million flowed into ETF MSOS during the first four days of the week, only about half of which was deployed into the market through Thursday. The model was launched in March 2017 targeting long-term investors seeking to invest in leading cannabis stocks with low portfolio turnover and has gained 283.3% since inception compared […]
Michigan generated $985 million in cannabis sales in 2020, and the program should continue to expand ahead as supply becomes more available and as distribution expands. …Read the full story
The resolution put forth to shareholders at the meeting in respect of the Transaction was approved by approximately 99.78% of the votes cast by TerrAscend minority shareholders. Completion of the Transaction remains conditional on the approval by the Ontario Superior Court of Justice and the satisfaction or waiver of certain other closing conditions. TerrAscend operates […]
This is reflected in our recently updated 2021 guidance, which, despite the near-term challenges, projects full-year organic growth of 18% to 23%, above our long-term 15% historical baseline growth, in addition to M&A growth of 19% to 20%. On October 25, 2021, the Company also entered into a new $125.0 million senior secured term loan […]
Investors are cautioned that this measure should not replace sales, net earnings or loss as an indicator of the Company’s performance, of its cash flows from operating, investing and financing activities or as a measure of its liquidity and cash flows. This is one of the key metrics that the Company uses to assess performance […]
CHICAGO, Nov. Caring Nature owns an active dispensary in Waterbury, CT; Connecticut Pharmaceutical Solutions owns an operating cultivation and production facility in Rocky Hill, CT; and Willow Brook Wellness holds an active dispensary in Meriden, CT. The transaction to acquire 100% of the equity interests of Willow Brook Wellness, LLC, includes one active dispensary in […]
, the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the first quarter fiscal 2022 ended September 30, 2021. On a run-rate basis to date, we have executed over $33 million in annualized cost savings and are positioned to deliver approximately $60 to $80 million in aggregate […]